SAM
FOLD

Sectoral Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Sectoral Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-43,300
Closed -$617K – 79
2025
Q4 		$617K Sell
43,300
-75,805
-64% -$745K 0.49% 55
2025
Q3 		$939K Sell
119,105
-480
-0.4% -$3.42K 0.58% 52
2025
Q2 		$685K Buy
119,585
+12,000
+11% +$77.4K 0.45% 60
2025
Q1 		$878K Sell
107,585
-28,035
-21% -$259K 0.68% 39
2024
Q4 		$1.28M Sell
135,620
-5,715
-4% -$59.4K 0.85% 32
2024
Q3 		$1.51M Sell
141,335
-75,509
-35% -$822K 0.89% 34
2024
Q2 		$2.15M Sell
216,844
-4,200
-2% -$43.1K 0.87% 34
2024
Q1 		$2.6M Buy
221,044
+64,275
+41% +$822K 1.02% 30
2023
Q4 		$2.22M Sell
156,769
-646,695
-80% -$7.34M 0.96% 36
2023
Q3 		$9.77M Buy
803,464
+73,540
+10% +$949K 1.9% 11
2023
Q2 		$9.17M Buy
729,924
+209,942
+40% +$2.49M 1.53% 20
2023
Q1 		$5.77M Buy
519,982
+12,300
+2% +$152K 1.11% 35
2022
Q4 		$6.2M Sell
507,682
-65,000
-11% -$732K 1.2% 30
2022
Q3 		$5.98M Buy
572,682
+11,800
+2% +$131K 1.18% 30
2022
Q2 		$6.02M Sell
560,882
-62,900
-10% -$518K 1.21% 30
2022
Q1 		$5.91M Sell
623,782
-619,100
-50% -$5.8M 1.05% 36
2021
Q4 		$14.4M Sell
1,242,882
-1,167,722
-48% -$13M 2.16% 12
2021
Q3 		$23M Buy
2,410,604
+319,200
+15% +$3.27M 1.91% 11
2021
Q2 		$20.2M Buy
2,091,404
+324,700
+18% +$3.17M 1.63% 17
2021
Q1 		$17.5M Buy
1,766,704
+232,100
+15% +$3.59M 1.32% 27
2020
Q4 		$35.4M Sell
1,534,604
-619,029
-29% -$12.7M 2.5% 10
2020
Q3 		$30.4M Buy
2,153,633
+402,720
+23% +$5.87M 2.61% 6
2020
Q2 		$26.4M Buy
1,750,913
+192,952
+12% +$2.35M 2.42% 4
2020
Q1 		$14.4M Sell
1,557,961
-502,000
-24% -$4.77M 2.76% 5
2019
Q4 		$20.1M Sell
2,059,961
-1,381,961
-40% -$12.7M 2.99% 5
2019
Q3 		$27.6M Buy
3,441,922
+117,299
+4% +$1.27M 4.76% 2
2019
Q2 		$41.5M Sell
3,324,623
-70,000
-2% -$888K 4.96% 2
2019
Q1 		$46.2M Sell
3,394,623
-1,641,967
-33% -$20.1M 5.55% 1
2018
Q4 		$48.3M Buy
5,036,590
+169,300
+3% +$1.86M 6.56% 1
2018
Q3 		$58.8M Buy
4,867,290
+1,173,600
+32% +$16.4M 6.25% 1
2018
Q2 		$57.7M Buy
3,693,690
+288,149
+8% +$4.36M 6.45% 1
2018
Q1 		$51.2M Buy
3,405,541
+554,772
+19% +$8.44M 5.62% 1
2017
Q4 		$41M Buy
2,850,769
+437,899
+18% +$6.02M 5.13% 1
2017
Q3 		$36.4M Sell
2,412,870
-1,071,120
-31% -$14.2M 4.69% 1
2017
Q2 		$35.1M Sell
3,483,990
-827,706
-19% -$6.66M 3.84% 6
2017
Q1 		$30.7M Sell
4,311,696
-788,502
-15% -$4.99M 3.59% 8
2016
Q4 		$25.3M Buy
5,100,198
+905,746
+22% +$6.27M 2.81% 18
2016
Q3 		$31M Sell
4,194,452
-594,286
-12% -$4.01M 3.05% 12
2016
Q2 		$26.1M Sell
4,788,738
-4,437,407
-48% -$31M 2.7% 18
2016
Q1 		$78M Buy
9,226,145
+1,252,709
+16% +$8.87M 3.77% 8
2015
Q4 		$77.3M Buy
7,973,436
+1,862,209
+30% +$16.8M 3.3% 11
2015
Q3 		$85.5M Buy
6,111,227
+1,106,905
+22% +$17.4M 3.92% 8
2015
Q2 		$70.8M Buy
5,004,322
+18,184
+0.4% +$219K 2.95% 12
2015
Q1 		$54.2M Buy
4,986,138
+220,640
+5% +$1.94M 2.06% 14
2014
Q4 		$39.6M Buy
4,765,498
+4,565,498
+2,283% +$31.3M 1.78% 18
2014
Q3 		$1.19M Buy
+200,000
New +$1.05M 0.05% 62

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Sectoral Asset Management's FOLD Position: Q1 2026 in Review

Sectoral Asset Management sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 43,300 shares — an estimated $617K sold.

Sectoral Asset Management first reported a position in FOLD in Q3 2014 and held it in 46 quarters. The position peaked at $85.5M in Q3 2015. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Sectoral Asset Management reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Sectoral Asset Management sold 43,300 Amicus Therapeutics shares in Q1 2026, an estimated $617K.
  • Sectoral Asset Management first reported a position in Amicus Therapeutics in Q3 2014 and held it in 46 quarters.
  • Sectoral Asset Management's Amicus Therapeutics position peaked at $85.5M in Q3 2015.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.